Urodynamic Equipment and Consumables Market Size By Product, By End Use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022

Description

List of Tables

The urodynamic equipment and consumables market revenue is projected to grow substantially over the forecast period from 2022 to 2030 primarily driven by the rising prevalence of bladder dysfunction across the globe.

Recently, mounting incidences of UTI (urinary tract infection) in women have increased the demand for urodynamic equipment and consumables. In 2019, there were about 404.61 million UTI infections, which resulted in 236,790 deaths. Furthermore, urodynamic testing is essential for determining detrusor instability and genuine stress incontinence.

Moreover, firms engaged in the urodynamic equipment and consumables market are working to improve their industry presence through product development, collaborations, investments in innovative technologies, and other strategies. For instance, in July 2022, Gemini Medical Technologies, a provider of urodynamic solutions, launched a new line of urodynamic equipment by MEDKONSULT Medical Technology, a leading manufacturer in the sector.

In another instance, in May 2020, Ambu Inc., a prominent medical device company, announced the release of Ambu aScope 4 Cysto, a cystoscope for the detection of urinary illnesses. The device is a single-use cystoscope with potential applications in clinical procedures like bladder cancer surveillance, stent removal, and other routine cystoscopy operations. This strategic product launch aided the firm in expanding its product portfolio and increasing its revenue.

The urodynamic equipment and consumables market has been bifurcated as per product, end use, and region.

Based on product, the market has been segmented into electromyographs, uroflowmetry equipment, cystometer, ambulatory urodynamic systems, video urodynamic systems, and urodynamic consumables. The electromyographs segment is expected to garner a substantial business share by the end of 2030. Electromyogram tests are widely employed for urinary problems caused by nerve or muscle injury, which is slated to boost overall segment growth.

In terms of end use, the urodynamic equipment and consumables market has been divided into ambulatory surgical centers, hospitals, and clinics. The ambulatory surgical centers segment held more than 29% revenue share in 2021 and is estimated to grow significantly from 2022 to 2030 owing to the increased volume of surgeries undertaken at ASCs. In addition, various advantages offered by ASCs, including cost efficacy, reduced wait time, enhanced personalization, improved quality of care, and mounting consumer demand for alternate venues of medical care, among others, are foreseen to aid the revenue growth of the segment in the forthcoming period.

In the regional landscape, the high prevalence of benign prostatic hyperplasia (BPH) in the Middle Eastern nations is foreseen to supplement the expansion of the urodynamic equipment and consumables market in the MEA region through 2030. Since BPH hampers patients' quality of life and is associated with high levels of co-morbid conditions, urodynamic procedures are gaining prominence for its treatment, which is set to promote industry growth in the Middle East & Africa.

Product Code: 3883

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Urodynamic equipment and consumables industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 End-use trends
- 2.1.4 Regional trends

Chapter 3 Urodynamic Equipment and Consumables Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increase in prevalence of lower urinary tract symptoms (LUTS) and urological disorders
  - 3.3.1.2 Growing awareness coupled with facilitative government initiatives for incontinence treatment
  - 3.3.1.3 Rising geriatric population
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 High cost of equipment and strict regulatory policies
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By end-use
3.5 COVID- 19 impact analysis
3.6 Technological advancements
3.7 Regulatory landscape
- 3.7.1 U.S.
- 3.7.2 Europe
3.8 Reimbursement scenario
3.9 Prevalence of urinary incontinence, 2021
3.10 Prevalence of prostate cancer, 2021
3.11 Porter's analysis
- 3.11.1 Industry rivalry
- 3.11.2 Suppliers power
- 3.11.3 Buyer power
- 3.11.4 Threat of substitute
- 3.11.5 Threat of new entrants
3.12 Competitive landscape, 2021
- 3.12.1 Company matrix analysis, 2021
3.13 PESTLE analysis
- 3.13.1 Political
- 3.13.2 Economical
- 3.13.3 Social
- 3.13.4 Technological
- 3.13.5 Legal
- 3.13.6 Environmental

Chapter 4 Urodynamic Equipment and Consumables Market, By Product

4.1 Key segment trends
4.2 Uroflowmetry equipment
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Cystometer
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Ambulatory urodynamic systems
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.5 Electromyographs
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
4.6 Video urodynamic systems
- 4.6.1 Market size, by region, 2017 - 2030 (USD Million)
4.7 Urodynamic consumables
- 4.7.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.2 Urodynamic Catheters
  - 4.7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.3 Urodynamic Pumps
  - 4.7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.4 Transducer Sets
  - 4.7.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Urodynamic Equipment and Consumables Market, By End-use

5.1 Key segment trends
5.2 Hospitals
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Clinics
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Ambulatory surgical centers
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Others
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Urodynamic Equipment and Consumables Market, By Region

6.1 Key regional trends
6.2 North America
- 6.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.2.2 Market size, by product, 2017 - 2030 (USD Million)
  - 6.2.2.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
- 6.2.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.2.4 U.S.
  - 6.2.4.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.2.4.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.2.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.2.5 Canada
  - 6.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.2.5.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.2.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
6.3 Europe
- 6.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.3.2 Market size, by product, 2017 - 2030 (USD Million)
  - 6.3.2.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
- 6.3.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.4 Germany
  - 6.3.4.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.3.4.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.3.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.5 UK
  - 6.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.3.5.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.3.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.6 France
  - 6.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.3.6.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.3.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.7 Italy
  - 6.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.3.7.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.3.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.8 Spain
  - 6.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.3.8.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.3.8.2 Market size, by end-use, 2017 - 2030 (USD Million)
6.4 Asia Pacific
- 6.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.4.2 Market size, by product, 2017 - 2030 (USD Million)
  - 6.4.2.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
- 6.4.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.4 China
  - 6.4.4.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.4.4.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.4.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.5 Japan
  - 6.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.4.5.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.4.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.6 India
  - 6.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.4.6.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.4.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.7 Australia
  - 6.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.4.7.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.4.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.8 South Korea
  - 6.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.4.8.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.4.8.2 Market size, by end-use, 2017 - 2030 (USD Million)
6.5 Latin America
- 6.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.5.2 Market size, by product, 2017 - 2030 (USD Million)
  - 6.5.2.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
- 6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5.4 Brazil
  - 6.5.4.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.5.4.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5.5 Mexico
  - 6.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.5.5.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.5.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5.6 Argentina
  - 6.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.5.6.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.5.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
6.6 MEA
- 6.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.6.2 Market size, by product, 2017 - 2030 (USD Million)
  - 6.6.2.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
- 6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6.4 South Africa
  - 6.6.4.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.6.4.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.6.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6.5 Saudi Arabia
  - 6.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.6.5.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.6.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6.6 UAE
  - 6.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 6.6.6.1.1 Market size, by urodynamic consumables, 2017 - 2030 (USD Million)
  - 6.6.6.2 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 7 Company Profiles

7.1 Competitive dashboard, 2021
7.2 Laborie Medical Technologies
- 7.2.1 Business Overview
- 7.2.2 Financial Data
- 7.2.3 Product Landscape
- 7.2.4 Strategic Outlook
- 7.2.5 SWOT Analysis
7.3 The Prometheus Group
- 7.3.1 Business Overview
- 7.3.2 Financial Data
- 7.3.3 Product Landscape
- 7.3.4 Strategic Outlook
- 7.3.5 SWOT Analysis
7.4 CooperSurgical
- 7.4.1 Business Overview
- 7.4.2 Financial Data
- 7.4.3 Product Landscape
- 7.4.4 Strategic Outlook
- 7.4.5 SWOT Analysis
7.5 Cook Medical
- 7.5.1 Business Overview
- 7.5.2 Financial Data
- 7.5.3 Product Landscape
- 7.5.4 Strategic Outlook
- 7.5.5 SWOT Analysis
7.6 Digitimer Ltd.
- 7.6.1 Business Overview
- 7.6.2 Financial Data
- 7.6.3 Product Landscape
- 7.6.4 Strategic Outlook
- 7.6.5 SWOT Analysis
7.7 Verathon Inc.
- 7.7.1 Business Overview
- 7.7.2 Financial Data
- 7.7.3 Product Landscape
- 7.7.4 Strategic Outlook
- 7.7.5 SWOT Analysis
7.8 Albyn Medical Ltd.
- 7.8.1 Business Overview
- 7.8.2 Financial Data
- 7.8.3 Product Landscape
- 7.8.4 Strategic Outlook
- 7.8.5 SWOT Analysis
7.9 Ambu Inc.
- 7.9.1 Business Overview
- 7.9.2 Financial Data
- 7.9.3 Product Landscape
- 7.9.4 Strategic Outlook
- 7.9.5 SWOT Analysis
7.10 MEDKONSULT Medical Technology
- 7.10.1 Business Overview
- 7.10.2 Financial Data
- 7.10.3 Product Landscape
- 7.10.4 Strategic Outlook
- 7.10.5 SWOT Analysis
7.11 SRS Medical
- 7.11.1 Business Overview
- 7.11.2 Financial Data
- 7.11.3 Product Landscape
- 7.11.4 Strategic Outlook
- 7.11.5 SWOT Analysis
7.12 Tic Medizintechnik
- 7.12.1 Business Overview
- 7.12.2 Financial Data
- 7.12.3 Product Landscape
- 7.12.4 Strategic Outlook
- 7.12.5 SWOT Analysis
7.13 HC Italia
- 7.13.1 Business Overview
- 7.13.2 Financial Data
- 7.13.3 Product Landscape
- 7.13.4 Strategic Outlook
- 7.13.5 SWOT Analysis
7.14 Stericom (P3 Medical)
- 7.14.1 Business Overview
- 7.14.2 Financial Data
- 7.14.3 Product Landscape
- 7.14.4 Strategic Outlook
- 7.14.5 SWOT Analysis
7.15 Santron Meditronic
- 7.15.1 Business Overview
- 7.15.2 Financial Data
- 7.15.3 Product Landscape
- 7.15.4 Strategic Outlook
- 7.15.5 SWOT Analysis